Alkeus Pharmaceuticals, Inc. is a private, late-stage biopharmaceutical company developing a novel treatment for Stargardt disease and dry age-rela ted macular degeneration (AMD). Stargardt disease is a progressive inherited retinal degenerative disease that causes irreversible vision loss leading to blindness. An estimated 40 to 60,000 people in the United States have this rare and serious condition. Symptoms typically begin in childhood or adolescence. There is currently no approved therapy for Stargardt disease. AMD is the number one cause of unpreventable blindness in the USA. There is currently no approved therapy for geographic atrophy, an advanced form of AMD.Read more
Alkeus Pharmaceuticals's Social Media
Popular SearchesALKEUS PHARMACEUTICALS IncAlkeus PharmaceuticalsAlkeus PharmaAlkeus Pharmaceuticals Security CorpSIC Code 28,283NAICS Code 32,325Show more
